Hacettepe University Medical School is a medical school located at Hacettepe University Medical Center in Ankara, Turkey.

During the past decade, Hacettepe Universitesi Tip Fakultesi conducted 25 clinical trials. In the 10-year time frame, 25 clinical trials started and 14 clinical trials were completed, i.e. on average, 56% percent of trials that started reached the finish line to date. In the past 5 years, 14 clinical trials started and 10 clinical trials were completed. i.e. 71.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hacettepe Universitesi Tip Fakultesi" #1 sponsor was "Pfizer" with 9 trials, followed by "Bayer" with 8 trials sponsored, "Amgen" with 6 trials sponsored, "Boehringer Ingelheim" with 2 trials sponsored and "Actelion" with 2 trials sponsored. Other sponsors include -1 different institutions and companies that sponsored additional 9 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hacettepe Universitesi Tip Fakultesi" #1 collaborator was "Regeneron Pharmaceuticals" with 2 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator, "Biomedical Advanced Research and Development Authority" with 1 trials as a collaborator, "Innovative Medicines Initiative (IMI) COMBACTE-CARE (EU)" with 1 trials as a collaborator and "Medivation LLC, a wholly owned subsidiary of Pfizer Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Hacettepe Universitesi Tip Fakultesi" are "Gastric Cancer" (2 trials), "Retinopathy of Prematurity (ROP)" (2 trials), "Venous Thromboembolism" (2 trials), "Active Juvenile Psoriatic Arthritis" (1 trials) and "Active Systemic Lupus Erythematosus" (1 trials). Many other conditions were trialed in "Hacettepe Universitesi Tip Fakultesi" in a lesser frequency.

Most popular intervention types in "Hacettepe Universitesi Tip Fakultesi" are "Drug" (24 trials), "Biological" (7 trials), "Other" (5 trials) and "Procedure" (2 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (11 trials), "Bemarituzumab" (2 trials), "Eylea (Aflibercept, BAY86-5321)" (2 trials), "Laser photocoagulation" (2 trials) and "PF-06651600" (2 trials). Other intervention names were less common.

The vast majority of trials in "Hacettepe Universitesi Tip Fakultesi" are 26 trials for "All" genders, 3 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hacettepe Universitesi Tip Fakultesi". undefined are not yet recruiting, 7 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 15 completed trials in Hacettepe Universitesi Tip Fakultesi, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Hacettepe Universitesi Tip Fakultesi, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 16 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 2 trials that are defined as “Not Applicable".